Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.

MLA

Qin, Jianzhong, et al. “Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.” Journal of Surgical Research, vol. 233, Jan. 2019, pp. 57–64. EBSCOhost, https://doi.org/10.1016/j.jss.2018.07.068.

APA

Qin, J., Kunda, N. M., Qiao, G., Tulla, K., Prabhakar, B. S., & Maker, A. V. (2019). Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases. Journal of Surgical Research, 233, 57–64. https://doi.org/10.1016/j.jss.2018.07.068

Chicago

Qin, Jianzhong, Nicholas M. Kunda, Guilin Qiao, Kiara Tulla, Bellur S. Prabhakar, and Ajay V. Maker. 2019. “Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.” Journal of Surgical Research 233 (January): 57–64. doi:10.1016/j.jss.2018.07.068.